XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Non- controlling Interest
Balance, beginning of year (in shares) at Dec. 31, 2019     53,010,875 1,732,352          
Balance, beginning of period at Dec. 31, 2019 $ 2,402,443 $ (115) $ 5 $ (265,730) $ 785,636 $ 2,028,734 $ (115) $ (146,919) $ 717
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options and vesting of RSU's and PSU's (in shares)     225,125            
Exercise of stock options and vesting of RSUs and PSUs (5,497)   $ 1   (5,498)        
Purchased common stock (in shares)     (108,819) (108,819)          
Purchased common stock (12,716)     $ (12,716)          
Stock-based compensation 8,430       8,430        
Net income 36,766         36,403     363
Foreign currency translation adjustments (73,417)             (73,198) (219)
Unrealized gain on derivatives 36             36  
Balance, end of period (in shares) at Mar. 31, 2020     53,127,181 1,841,171          
Balance, end of period at Mar. 31, 2020 2,355,930   $ 6 $ (278,446) 788,568 2,065,022   (220,081) 861
Balance, beginning of year (in shares) at Dec. 31, 2020     53,427,234 2,034,012          
Balance, beginning of period at Dec. 31, 2020 2,594,111   $ 6 $ (303,614) 854,301 2,188,191   (146,065) 1,292
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options and vesting of RSU's and PSU's (in shares)     211,537            
Exercise of stock options and vesting of RSUs and PSUs 4,981       4,981        
Purchased common stock (in shares)     (14,906) (14,906)          
Purchased common stock (3,048)     $ (3,048)          
Stock-based compensation 8,815       8,815        
Net income 68,222         68,127     95
Foreign currency translation adjustments (32,479)             (32,260) (219)
Unrealized gain on derivatives 68             68  
Balance, end of period (in shares) at Mar. 31, 2021     53,623,865 2,048,918          
Balance, end of period at Mar. 31, 2021 $ 2,640,670   $ 6 $ (306,662) $ 868,097 $ 2,256,318   $ (178,257) $ 1,168